Article Details

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Recommendation of “Buy” by Analysts

Retrieved on: 2025-03-09 13:33:16

Tags for this article:

Click the tags to see associated articles and topics

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Recommendation of “Buy” by Analysts. View article details on hiswai:

Excerpt

Two Sigma Investments LP now owns 751,894 shares of the company's stock valued at $1,707,000 after purchasing an additional 331,417 shares during the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo